News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
757,540 Results
Type
Article (45605)
Company Profile (332)
Press Release (711585)
Multimedia
Podcasts (125)
Webinars (22)
Section
Business (212515)
Career Advice (2119)
Deals (36557)
Drug Delivery (136)
Drug Development (82751)
Employer Resources (177)
FDA (17048)
Job Trends (15439)
News (357737)
Policy (33639)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2746)
Accelerated approval (44)
Adcomms (25)
Allergies (170)
Alliances (52623)
ALS (201)
Alzheimer's disease (1786)
Antibody-drug conjugate (ADC) (440)
Approvals (17390)
Artificial intelligence (673)
Autoimmune disease (252)
Automation (54)
Bankruptcy (367)
Best Places to Work (11930)
BIOSECURE Act (20)
Biosimilars (215)
Biotechnology (221)
Bladder cancer (184)
Brain cancer (69)
Breast cancer (719)
Cancer (5667)
Cardiovascular disease (462)
Career advice (1801)
Career pathing (42)
CAR-T (326)
CDC (56)
Celiac Disease (2)
Cell therapy (858)
Cervical cancer (44)
Clinical research (71333)
Collaboration (2076)
Company closure (5)
Compensation (1336)
Complete response letters (77)
COVID-19 (2820)
CRISPR (108)
C-suite (1084)
Cystic fibrosis (155)
Data (7500)
Decentralized trials (3)
Denatured (45)
Depression (159)
Dermatology (71)
Diabetes (565)
Diagnostics (7169)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (322)
Drug pricing (198)
Drug shortages (33)
Duchenne muscular dystrophy (277)
Earnings (92982)
Editorial (64)
Employer branding (22)
Employer resources (157)
Events (123803)
Executive appointments (1092)
FDA (20674)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1723)
Gene editing (231)
Generative AI (61)
Gene therapy (706)
GLP-1 (1051)
Government (4821)
Grass and pollen (7)
Guidances (405)
Healthcare (19689)
HIV (80)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (282)
Immuno-oncology (88)
Indications (168)
Infectious disease (3161)
Inflammatory bowel disease (211)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (286)
Interviews (329)
IPO (17004)
IRA (51)
Job creations (3835)
Job search strategy (1502)
JPM (62)
Kidney cancer (18)
Labor market (97)
Layoffs (573)
Leadership (39)
Legal (8175)
Liver cancer (100)
Longevity (31)
Lung cancer (751)
Lymphoma (419)
Machine learning (59)
Management (63)
Manufacturing (1000)
MASH (180)
Medical device (14638)
Medtech (14727)
Mergers & acquisitions (20765)
Metabolic disorders (1455)
mRNA (211)
Multiple sclerosis (180)
NASH (17)
Neurodegenerative disease (398)
Neuropsychiatric disorders (101)
Neuroscience (3253)
Neurotech (1)
NextGen: Class of 2026 (6855)
Non-profit (4663)
Now hiring (75)
Obesity (681)
Opinion (298)
Ovarian cancer (208)
Pain (243)
Pancreatic cancer (284)
Parkinson's disease (354)
Partnered (34)
Patents (580)
Patient recruitment (642)
Peanut (64)
People (61703)
Pharmaceutical (67)
Pharmacy benefit managers (32)
Phase 1 (22398)
Phase 2 (31389)
Phase 3 (23266)
Pipeline (7748)
Policy (316)
Postmarket research (2585)
Preclinical (9617)
Press Release (71)
Prostate cancer (288)
Psychedelics (52)
Radiopharmaceuticals (337)
Rare diseases (1034)
Real estate (6292)
Recruiting (70)
Regulatory (25809)
Reports (55)
Research institute (2553)
Resumes & cover letters (365)
Rett syndrome (34)
RNA editing (22)
RSV (89)
Schizophrenia (173)
Series A (288)
Series B (210)
Service/supplier (14)
Sickle cell disease (110)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (47)
Startups (3898)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (77)
Vaccines (1117)
Venture capital (107)
Weight loss (439)
Women's health (121)
Worklife (20)
Date
Today (172)
Last 7 days (809)
Last 30 days (2816)
Last 365 days (31149)
2026 (10025)
2025 (30957)
2024 (36211)
2023 (41135)
2022 (52398)
2021 (56993)
2020 (55611)
2019 (48407)
2018 (36441)
2017 (33540)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (780)
Alabama (94)
Alaska (7)
Arizona (349)
Arkansas (16)
Asia (42293)
Australia (7041)
California (12864)
Canada (3653)
China (1316)
Colorado (553)
Connecticut (560)
Delaware (392)
Europe (93083)
Florida (1908)
Georgia (421)
Hawaii (3)
Idaho (65)
Illinois (1036)
India (88)
Indiana (589)
Iowa (24)
Japan (521)
Kansas (133)
Kentucky (50)
Louisiana (41)
Maine (75)
Maryland (1541)
Massachusetts (9278)
Michigan (378)
Minnesota (711)
Mississippi (7)
Missouri (155)
Montana (36)
Nebraska (29)
Nevada (141)
New Hampshire (91)
New Jersey (3409)
New Mexico (30)
New York (3386)
North Carolina (1655)
North Dakota (10)
Northern California (6372)
Ohio (386)
Oklahoma (25)
Oregon (45)
Pennsylvania (2585)
Puerto Rico (29)
Rhode Island (51)
South America (1170)
South Carolina (86)
South Dakota (2)
Southern California (5065)
Tennessee (207)
Texas (2049)
United States (45725)
Utah (387)
Vermont (1)
Virginia (307)
Washington D.C. (81)
Washington State (1043)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
757,540 Results for "bioaffinity technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice
March 25, 2026
·
5 min read
Press Releases
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16
April 7, 2026
·
5 min read
Press Releases
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026
April 2, 2026
·
7 min read
Press Releases
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients
March 3, 2026
·
5 min read
Press Releases
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy
April 15, 2026
·
5 min read
Press Releases
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study
February 17, 2026
·
5 min read
Press Releases
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
March 13, 2026
·
15 min read
Press Releases
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures
March 17, 2026
·
4 min read
Press Releases
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic
March 10, 2026
·
6 min read
Press Releases
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
January 8, 2026
·
5 min read
1 of 75,754
Next
